BULLFROG AI HOLDINGS, INC. Repayments of Other Short-term Debt
BULLFROG AI HOLDINGS, INC. (BFRG) reported Repayments of Other Short-term Debt of $85.06 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherShortTermDebt · last filed 2026-08-14
- BULLFROG AI HOLDINGS, INC. repayments of other short-term debt for the quarter ending 2026-06-30 was $43.75K, a 18.65% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. repayments of other short-term debt for the quarter ending 2026-03-31 was $41.31K, a 133.02% increase year-over-year.
- BULLFROG AI HOLDINGS, INC. repayments of other short-term debt for the quarter ending 2025-12-31 was $55.61K, a 67.67% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. repayments of other short-term debt for the quarter ending 2025-09-30 was $54.69K, a 67.65% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. repayments of other short-term debt for fiscal 2025 was $181.80K, a 67.65% decline from fiscal 2024.
- BULLFROG AI HOLDINGS, INC. repayments of other short-term debt for fiscal 2024 was $561.88K, a 19.45% decline from fiscal 2023.
- BULLFROG AI HOLDINGS, INC. repayments of other short-term debt for fiscal 2023 was $697.53K.
| Period end | Repayments of Other Short-term Debt 3 month | Repayments of Other Short-term Debt 6 month | Repayments of Other Short-term Debt 9 month | Repayments of Other Short-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $43.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $85.06K 10-Q · filed 2026-08-14 | $140.66K derived: sum of 3 quarters · filed 2026-08-14 | $195.35K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $41.31K 10-Q · filed 2026-05-14 | $96.91K derived: sum of 2 quarters · filed 2026-05-14 | $151.60K derived: sum of 3 quarters · filed 2026-05-14 | $205.38K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $55.61K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $110.29K derived: sum of 2 quarters · filed 2026-03-19 | $164.07K derived: sum of 3 quarters · filed 2026-08-14 | $181.80K 10-K · filed 2026-03-19 |
| 2025-09-30 | $54.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $108.46K derived: sum of 2 quarters · filed 2026-08-14 | $126.19K 10-Q · filed 2025-11-14 | $298.20K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $53.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $71.51K 10-Q · filed 2026-08-14 | $243.51K derived: sum of 3 quarters · filed 2026-08-14 | $412.55K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $17.73K 10-Q · filed 2026-05-14 | $189.73K derived: sum of 2 quarters · filed 2026-05-14 | $358.77K derived: sum of 3 quarters · filed 2026-05-14 | $524.88K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $172.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $341.04K derived: sum of 2 quarters · filed 2026-03-19 | $507.15K derived: sum of 3 quarters · filed 2026-03-19 | $561.88K 10-K · filed 2026-03-19 |
| 2024-09-30 | $169.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $335.15K derived: sum of 2 quarters · filed 2025-11-14 | $389.88K 10-Q · filed 2025-11-14 | $603.17K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $166.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $220.84K 10-Q · filed 2025-08-13 | $434.13K derived: sum of 3 quarters · filed 2025-08-13 | $643.90K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $54.73K 10-Q · filed 2025-05-13 | $268.02K derived: sum of 2 quarters · filed 2025-05-13 | $477.78K derived: sum of 3 quarters · filed 2025-05-13 | $684.22K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $213.29K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $423.05K derived: sum of 2 quarters · filed 2025-03-14 | $629.49K derived: sum of 3 quarters · filed 2025-03-14 | $697.53K 10-K · filed 2025-03-14 |
| 2023-09-30 | $209.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $416.20K derived: sum of 2 quarters · filed 2024-11-08 | $484.24K 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $206.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $274.48K 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $68.05K 10-Q · filed 2024-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |